Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience

Detalles Bibliográficos
Autores principales: Gaviani, P., Simonetti, G., Salmaggi, A., Lamperti, E., Silvani, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684713/
https://www.ncbi.nlm.nih.gov/pubmed/23703296
http://dx.doi.org/10.1007/s11060-013-1147-x
_version_ 1782273595181891584
author Gaviani, P.
Simonetti, G.
Salmaggi, A.
Lamperti, E.
Silvani, A.
author_facet Gaviani, P.
Simonetti, G.
Salmaggi, A.
Lamperti, E.
Silvani, A.
author_sort Gaviani, P.
collection PubMed
description
format Online
Article
Text
id pubmed-3684713
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-36847132013-06-20 Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience Gaviani, P. Simonetti, G. Salmaggi, A. Lamperti, E. Silvani, A. J Neurooncol Clinical Study Springer US 2013-05-24 2013 /pmc/articles/PMC3684713/ /pubmed/23703296 http://dx.doi.org/10.1007/s11060-013-1147-x Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Clinical Study
Gaviani, P.
Simonetti, G.
Salmaggi, A.
Lamperti, E.
Silvani, A.
Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
title Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
title_full Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
title_fullStr Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
title_full_unstemmed Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
title_short Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
title_sort safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684713/
https://www.ncbi.nlm.nih.gov/pubmed/23703296
http://dx.doi.org/10.1007/s11060-013-1147-x
work_keys_str_mv AT gavianip safetyofsecondlinechemotherapywithnonconventionalfotemustinescheduleinrecurrenthighgradegliomasasingleinstitutionexperience
AT simonettig safetyofsecondlinechemotherapywithnonconventionalfotemustinescheduleinrecurrenthighgradegliomasasingleinstitutionexperience
AT salmaggia safetyofsecondlinechemotherapywithnonconventionalfotemustinescheduleinrecurrenthighgradegliomasasingleinstitutionexperience
AT lampertie safetyofsecondlinechemotherapywithnonconventionalfotemustinescheduleinrecurrenthighgradegliomasasingleinstitutionexperience
AT silvania safetyofsecondlinechemotherapywithnonconventionalfotemustinescheduleinrecurrenthighgradegliomasasingleinstitutionexperience

Ejemplares similares